Finance

Lists
CAMX:STO
Camurus AB
SEK ७२५.५०
-१.९६%
(-१४.५०) 1D
नोभेम्बर १७, १५:४७:२८ GMT+१  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for CAMX...
Open
SEK ७३६.००
High
SEK ७३९.००
Low
SEK ७२४.५०
Mkt. cap
४४.८१ अरब
Avg. vol.
१.०७ लाख
Volume
५०.१४ हजार
52-wk high
SEK ७५०.००
52-wk low
SEK ४३०.८०
Shares outstanding
६.०६ करोड
No. of employees
३२३
Open
SEK ७३६.००
High
SEK ७३९.००
Low
SEK ७२४.५०
Mkt. cap
४४.८१ अरब
Avg. vol.
१.०७ लाख
Volume
५०.१४ हजार
52-wk high
SEK ७५०.००
52-wk low
SEK ४३०.८०
Shares outstanding
६.०६ करोड
No. of employees
३२३
News stories
From web sources and news partners
ChartMill
ChartMill
·
१ घण्टा पहिले
S&P 500 Premarket Movers on Nov. 17: Gainers and Losers
The Motley Fool
The Motley Fool
·
३१ मिनेट पहिले
Prediction: Dec. 9 Will Mark a Turning Point for the S&P 500
Traders Union
Traders Union
·
४७ मिनेट पहिले
S&P 500 could deliver 18% total return by 2027, Goldman Sachs projects
Profile
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap. Camurus was founded by scientists in biophysical, food, and pharmaceutical chemistry with expertise in lipid phase structures. The company provides nanoscale drug-delivery systems for development of high-value therapeutics. Wikipedia
About Camurus AB
CEOFredrik Tiberg
Employees३२३
Founded१९९१
Headquarters-
SectorHealth Care
Industry-
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
४६.४५ करोड
५३.३१ करोड
७०.२१ करोड
७२.४० करोड
Cost of goods sold
३.६४ करोड
३.७२ करोड
४.४१ करोड
४.६४ करोड
Cost of revenue
३.६४ करोड
३.७२ करोड
४.४१ करोड
४.६४ करोड
Research and development expenses
१२.४९ करोड
१३.७६ करोड
१२.५२ करोड
१४.१९ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१८.४५ करोड
१७.७५ करोड
२३.२३ करोड
२०.५१ करोड
Operating expense
३०.४१ करोड
३२.७५ करोड
३६.५४ करोड
३५.५७ करोड
Total operating expenses
३४.०४ करोड
३६.४७ करोड
४०.९६ करोड
४०.२१ करोड
Operating income
१२.४० करोड
१६.८४ करोड
२९.२५ करोड
३२.१९ करोड
Other non operating income
-१७.०० हजार
-
-
-
EBT including unusual items
१२.६८ करोड
१८.३९ करोड
३०.९७ करोड
३४.०५ करोड
EBT excluding unusual items
१२.६८ करोड
१८.३९ करोड
३०.९७ करोड
३४.०५ करोड
Income tax expense
२.६० करोड
४.०० करोड
६.८९ करोड
७.०६ करोड
Effective tax rate
२०.४७%
२१.७८%
२२.२३%
२०.७२%
Other operating expenses
-५३.५७ लाख
१.२४ करोड
७९.५३ लाख
८७.०८ लाख
Net income
१०.०९ करोड
१४.३८ करोड
२४.०८ करोड
२७.०० करोड
Net profit margin
२१.७२%
२६.९८%
३४.३०%
३७.२९%
Earnings per share
१.६७
२.४०
४.०५
४.५३
Interest and investment income
१.५५ करोड
१.६९ करोड
१.८६ करोड
२.०१ करोड
Interest expense
-१४.५९ लाख
-१४.७४ लाख
-१४.१६ लाख
-१४.७२ लाख
Net interest expenses
१.४१ करोड
१.५५ करोड
१.७२ करोड
१.८६ करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
१३.०७ करोड
१७.५३ करोड
२९.९६ करोड
३२.९१ करोड
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू